Ascletis is an innovative R&D driven biotech with two commercial products and listed on Hong Kong Stock Exchange (Ascletis, 1672.HK). Ascletis’ mission is to address unmet medical needs in three therapeutic areas: viral, cancer and fatty liver diseases. Led by a management team with deep expertise and a proven track record, Ascletis has developed a fully integrated platform covering the entire value chain from discovery and development to manufacturing and commercialization.

Biotechnology

Ascletis

Jinzi J. Wu

Judy Wu

Yuemei Yan

Handan He

Ascletis' Leadership Team includes Yuemei Yan and 3 others.

��

Leadership Team

About

Team members

��������

Leadership Team

About

Team members

��